Industry manufacturer, Sunrise Medical, has had to increase UK stock levels of its Sterling mobility scooters because of higher-than-expected demand.
A statement from the company said it has recently seen “unprecedented demand” for both the Sterling S425 and S700 and as a result has stocked out on those items.
The company has also had to order in more Q100 powerchairs to cope with demand for the equipment.
The Q100 launched recently but has already sold around 1,000 units. It sold in its hundreds in the first few months of its launch.
Last month Sunrise reviewed how it could reduce the possibility of running out of stock on its Sterling range again and so decided to increase its UK stock holdings of the S425 and S700.
It has moved stock of the S400 scooter to its European Distribution Centre which means the lead time for the S400 has increased to five working days once the order has been received.
The company said that it “frequently reviews” any overdue deliveries to provide a good service to its dealers.
The Q100’s launch was part of Sunrise’s overhaul and consolidation of its entire powerchair portfolio, which saw it rebadged as the Q-series to make the range simpler for trade customers and end-users to understand.
One of the company’s largest-ever launches saw six powerchairs from the very low-end to the very high-end released, as well as improvements on current models to make them easier for dealers to service and maintain.
The Q100, the Q-Series’ entry-level compact powerchair, sold 600 units in its first three months and spearheaded Sunrise’s multiple mobility trade launch events held for its existing dealer network.